The Impact of COVID-19 is included in Thyroid Eye Disease Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Thyroid Eye Disease Trends and Forecast
The future of the global thyroid eye disease market looks promising with opportunities in the hospital and clinic markets. The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Thyroid Eye Disease by Segment
The study includes a forecast for the global thyroid eye disease by treatment type, route of administration, product, end use industry, and region.
Thyroid Eye Disease Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:
• Corticosteroids
• Vitamins
• Monoclonal Antibody
• Others
Thyroid Eye Disease Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Oral
• Topical
• Parenteral
Thyroid Eye Disease Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Tablet
• Capsule
• Ointment
• Solution
Thyroid Eye Disease Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Clinics
• Others
Thyroid Eye Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Thyroid Eye Disease Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid eye disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid eye disease companies profiled in this report include-
• Abbvie
• Novartis International
• Teva Pharmaceutical Industries
• Pfizer
• Sanofi S.A.
• Merck
• Abbot Laboratories
• Horizon Therapeutics
• Johnson & Johnson
• GE Healthcare
Thyroid Eye Disease Market Insights
Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
Within this market, hospitals will remain the largest segment.
APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.
Features of the Global Thyroid Eye Disease Market
Market Size Estimates: Thyroid Eye Disease Market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Thyroid Eye Disease Market by various segments, such as by treatment type, route of administration, product, end use industry and region in terms of($B).
Regional Analysis: Thyroid Eye Disease Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different treatment types, route of administrations, products, end use industries, and regions for the thyroid eye disease market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid eye disease market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the thyroid eye disease market size?
Answer: The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030.
Q.2 What is the growth forecast for thyroid eye disease market?
Answer: The global thyroid eye disease market is expected to grow with a CAGR of 8.1% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the thyroid eye disease market?
Answer: The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.
Q4. What are the major segments for thyroid eye disease market?
Answer: The future of the thyroid eye disease market looks promising with opportunities in the hospital and clinic markets.
Q5. Who are the key thyroid eye disease market companies?
Answer: Some of the key thyroid eye disease companies are as follows:
• AbbVie
• Novartis International
• Teva Pharmaceutical Industries
• Pfizer
• Sanofi S.A.
• Merck
• Abbot Laboratories
• Horizon Therapeutics
• Johnson & Johnson
• GE Healthcare
Q6. Which thyroid eye disease market segment will be the largest in future?
Answer: Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
Q7. In thyroid eye disease market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the thyroid eye disease market by treatment type (corticosteroids, vitamins, monoclonal antibody, and others), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), end use industry (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to thyroid eye disease market or related to thyroid eye disease companies, thyroid eye disease market size, thyroid eye disease market share, thyroid eye disease market growth, thyroid eye disease market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Thyroid Eye Disease Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Thyroid Eye Disease Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Thyroid Eye Disease Market by Treatment Type
3.3.1: Corticosteroids
3.3.2: Vitamins
3.3.3: Monoclonal Antibody
3.3.4: Others
3.4: Global Thyroid Eye Disease Market by Route of Administration
3.4.1: Oral
3.4.2: Topical
3.4.3: Parenteral
3.5: Global Thyroid Eye Disease Market by Product
3.5.1: Tablet
3.5.2: Capsule
3.5.3: Ointment
3.5.4: Solution
3.6: Global Thyroid Eye Disease Market by End Use Industry
3.6.1: Hospitals
3.6.2: Clinics
3.6.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Thyroid Eye Disease Market by Region
4.2: North American Thyroid Eye Disease Market
4.2.1: North American Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.2.2: North American Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.3: European Thyroid Eye Disease Market
4.3.1: European Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.3.2: European Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.4: APAC Thyroid Eye Disease Market
4.4.1: APAC Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.4.2: APAC Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.5: ROW Thyroid Eye Disease Market
4.5.1: ROW Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.5.2: ROW Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Thyroid Eye Disease Market by Treatment Type
6.1.2: Growth Opportunities for the Global Thyroid Eye Disease Market by Route of Administration
6.1.3: Growth Opportunities for the Global Thyroid Eye Disease Market by Product
6.1.4: Growth Opportunities for the Global Thyroid Eye Disease Market by End Use Industry
6.1.5: Growth Opportunities for the Global Thyroid Eye Disease Market by Region
6.2: Emerging Trends in the Global Thyroid Eye Disease Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Thyroid Eye Disease Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Eye Disease Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: AbbVie
7.2: Novartis International
7.3: Teva Pharmaceutical Industries
7.4: Pfizer
7.5: Sanofi S.A.
7.6: Merck
7.7: Abbot Laboratories
7.8: Horizon Therapeutics
7.9: Johnson & Johnson
7.10: GE Healthcare
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Thyroid Eye Disease Market Report.